United States · FDA National Drug Code directory
Guaifenesin and Pseudoephedrine HCl
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-833_436b7cb6-bc72-4b51-986e-22ad631ce0a2
- Product NDC
- 58602-833
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guaifenesin and Pseudoephedrine HCl
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200325
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 600 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (58602-833-12) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 58602-833-12
- 2 BLISTER PACK in 1 CARTON (58602-833-17) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 58602-833-17
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →